nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—esophageal cancer	0.91	1	CiPCiCtD
Decitabine—DCK—Pyrimidine salvage reactions—TYMP—esophageal cancer	0.00327	0.137	CbGpPWpGaD
Decitabine—DNMT3A—digestive system—esophageal cancer	0.00175	0.122	CbGeAlD
Decitabine—DCK—Pyrimidine metabolism—TYMP—esophageal cancer	0.00149	0.0623	CbGpPWpGaD
Decitabine—DNMT3A—lung—esophageal cancer	0.00146	0.102	CbGeAlD
Decitabine—DNMT1—epithelium—esophageal cancer	0.00139	0.0972	CbGeAlD
Decitabine—DNMT1—bronchus—esophageal cancer	0.00137	0.0957	CbGeAlD
Decitabine—Floxuridine—TYMP—esophageal cancer	0.00129	0.479	CrCbGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—ARID1A—esophageal cancer	0.00128	0.0535	CbGpPWpGaD
Decitabine—DNMT1—trachea—esophageal cancer	0.00123	0.086	CbGeAlD
Decitabine—DNMT1—digestive system—esophageal cancer	0.00106	0.074	CbGeAlD
Decitabine—DNMT3A—DNA methylation—HIST1H2BM—esophageal cancer	0.00104	0.0435	CbGpPWpGaD
Decitabine—Trifluridine—TYMP—esophageal cancer	0.00102	0.38	CrCbGaD
Decitabine—DNMT3A—lymph node—esophageal cancer	0.000999	0.0698	CbGeAlD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—HIST1H2BM—esophageal cancer	0.000947	0.0395	CbGpPWpGaD
Decitabine—DCK—bronchus—esophageal cancer	0.000947	0.0662	CbGeAlD
Decitabine—DNMT1—lung—esophageal cancer	0.000883	0.0618	CbGeAlD
Decitabine—DCK—trachea—esophageal cancer	0.00085	0.0595	CbGeAlD
Decitabine—DCK—digestive system—esophageal cancer	0.000731	0.0512	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—KDM6A—esophageal cancer	0.000723	0.0302	CbGpPWpGaD
Decitabine—DNMT1—DNA methylation—HIST1H2BM—esophageal cancer	0.000705	0.0294	CbGpPWpGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—HIST1H2BM—esophageal cancer	0.00064	0.0267	CbGpPWpGaD
Decitabine—DCK—lung—esophageal cancer	0.000611	0.0427	CbGeAlD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—HIST1H2BM—esophageal cancer	0.000607	0.0253	CbGpPWpGaD
Decitabine—DNMT1—lymph node—esophageal cancer	0.000604	0.0422	CbGeAlD
Decitabine—DCK—Nucleotide metabolism—TYMP—esophageal cancer	0.000582	0.0243	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—SMAD4—esophageal cancer	0.000568	0.0237	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—ARID1A—esophageal cancer	0.000548	0.0229	CbGpPWpGaD
Decitabine—DNMT1—NoRC negatively regulates rRNA expression—HIST1H2BM—esophageal cancer	0.000473	0.0198	CbGpPWpGaD
Decitabine—DNMT1—Negative epigenetic regulation of rRNA expression—HIST1H2BM—esophageal cancer	0.000462	0.0193	CbGpPWpGaD
Decitabine—DCK—lymph node—esophageal cancer	0.000418	0.0292	CbGeAlD
Decitabine—DNMT1—Epigenetic regulation of gene expression—HIST1H2BM—esophageal cancer	0.00041	0.0171	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—HIST1H2BM—esophageal cancer	0.000383	0.016	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—ABL1—esophageal cancer	0.000382	0.0159	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.00037	0.0154	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—BCL2—esophageal cancer	0.000327	0.0137	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—ACTB—esophageal cancer	0.000326	0.0136	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—esophageal cancer	0.000318	0.0133	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.000306	0.0128	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.000306	0.0128	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MET—esophageal cancer	0.000283	0.0118	CbGpPWpGaD
Decitabine—Hypoxia—Methotrexate—esophageal cancer	0.000282	0.00575	CcSEcCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—esophageal cancer	0.000281	0.0117	CbGpPWpGaD
Decitabine—Contusion—Capecitabine—esophageal cancer	0.000276	0.00562	CcSEcCtD
Decitabine—Chest discomfort—Capecitabine—esophageal cancer	0.000272	0.00555	CcSEcCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1A—esophageal cancer	0.000272	0.0113	CbGpPWpGaD
Decitabine—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.000266	0.00543	CcSEcCtD
Decitabine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000265	0.0054	CcSEcCtD
Decitabine—Cellulitis—Capecitabine—esophageal cancer	0.000265	0.0054	CcSEcCtD
Decitabine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000261	0.00533	CcSEcCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—EP300—esophageal cancer	0.000258	0.0108	CbGpPWpGaD
Decitabine—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000254	0.00519	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.000253	0.0106	CbGpPWpGaD
Decitabine—Bone pain—Capecitabine—esophageal cancer	0.000251	0.00512	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CREBBP—esophageal cancer	0.000247	0.0103	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—RB1—esophageal cancer	0.000246	0.0103	CbGpPWpGaD
Decitabine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000245	0.00499	CcSEcCtD
Decitabine—DNMT3A—RMTs methylate histone arginines—CCND1—esophageal cancer	0.000244	0.0102	CbGpPWpGaD
Decitabine—Pulmonary embolism—Capecitabine—esophageal cancer	0.000241	0.00491	CcSEcCtD
Decitabine—Hyponatraemia—Cisplatin—esophageal cancer	0.000238	0.00485	CcSEcCtD
Decitabine—Pleural effusion—Methotrexate—esophageal cancer	0.000234	0.00477	CcSEcCtD
Decitabine—Fungal infection—Methotrexate—esophageal cancer	0.000232	0.00473	CcSEcCtD
Decitabine—Candida infection—Capecitabine—esophageal cancer	0.00023	0.00468	CcSEcCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—esophageal cancer	0.000225	0.0094	CbGpPWpGaD
Decitabine—Dehydration—Cisplatin—esophageal cancer	0.00022	0.00449	CcSEcCtD
Decitabine—Petechiae—Methotrexate—esophageal cancer	0.000218	0.00444	CcSEcCtD
Decitabine—Ecchymosis—Capecitabine—esophageal cancer	0.000218	0.00444	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—esophageal cancer	0.000216	0.00903	CbGpPWpGaD
Decitabine—Hypokalaemia—Cisplatin—esophageal cancer	0.000216	0.0044	CcSEcCtD
Decitabine—Lamivudine—ABCC2—esophageal cancer	0.000215	0.0797	CrCbGaD
Decitabine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000213	0.00435	CcSEcCtD
Decitabine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000212	0.00432	CcSEcCtD
Decitabine—Sepsis—Capecitabine—esophageal cancer	0.000209	0.00426	CcSEcCtD
Decitabine—Ear pain—Capecitabine—esophageal cancer	0.000205	0.00417	CcSEcCtD
Decitabine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000201	0.00409	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000197	0.00823	CbGpPWpGaD
Decitabine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000197	0.00402	CcSEcCtD
Decitabine—Pancytopenia—Cisplatin—esophageal cancer	0.000194	0.00397	CcSEcCtD
Decitabine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000184	0.00376	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND1—esophageal cancer	0.000183	0.00763	CbGpPWpGaD
Decitabine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00018	0.00367	CcSEcCtD
Decitabine—Renal failure—Cisplatin—esophageal cancer	0.000179	0.00366	CcSEcCtD
Decitabine—Pulmonary embolism—Methotrexate—esophageal cancer	0.000179	0.00365	CcSEcCtD
Decitabine—Myocardial infarction—Cisplatin—esophageal cancer	0.000179	0.00365	CcSEcCtD
Decitabine—Lethargy—Capecitabine—esophageal cancer	0.000178	0.00363	CcSEcCtD
Decitabine—Stomatitis—Cisplatin—esophageal cancer	0.000178	0.00363	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN1A—esophageal cancer	0.000177	0.00738	CbGpPWpGaD
Decitabine—Hyponatraemia—Capecitabine—esophageal cancer	0.000175	0.00358	CcSEcCtD
Decitabine—Pain in extremity—Capecitabine—esophageal cancer	0.000175	0.00356	CcSEcCtD
Decitabine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000173	0.00352	CcSEcCtD
Decitabine—DNMT1—Regulation of retinoblastoma protein—EP300—esophageal cancer	0.000168	0.00702	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.000163	0.00682	CbGpPWpGaD
Decitabine—Dehydration—Capecitabine—esophageal cancer	0.000162	0.00331	CcSEcCtD
Decitabine—Ecchymosis—Methotrexate—esophageal cancer	0.000162	0.0033	CcSEcCtD
Decitabine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000162	0.0033	CcSEcCtD
Decitabine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000161	0.00329	CcSEcCtD
Decitabine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000161	0.00328	CcSEcCtD
Decitabine—Urethral disorder—Cisplatin—esophageal cancer	0.000161	0.00328	CcSEcCtD
Decitabine—Dry skin—Capecitabine—esophageal cancer	0.00016	0.00326	CcSEcCtD
Decitabine—Abdominal pain upper—Capecitabine—esophageal cancer	0.00016	0.00325	CcSEcCtD
Decitabine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000159	0.00325	CcSEcCtD
Decitabine—Hypokalaemia—Capecitabine—esophageal cancer	0.000159	0.00324	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000157	0.00321	CcSEcCtD
Decitabine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000156	0.00318	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—SMG6—esophageal cancer	0.000156	0.00651	CbGpPWpGaD
Decitabine—Sepsis—Methotrexate—esophageal cancer	0.000155	0.00317	CcSEcCtD
Decitabine—Muscular weakness—Capecitabine—esophageal cancer	0.000154	0.00314	CcSEcCtD
Decitabine—Eye disorder—Cisplatin—esophageal cancer	0.000153	0.00312	CcSEcCtD
Decitabine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000152	0.00311	CcSEcCtD
Decitabine—Cardiac disorder—Cisplatin—esophageal cancer	0.000152	0.0031	CcSEcCtD
Decitabine—Abdominal distension—Capecitabine—esophageal cancer	0.000152	0.0031	CcSEcCtD
Decitabine—Dysphagia—Capecitabine—esophageal cancer	0.000151	0.00308	CcSEcCtD
Decitabine—Immune system disorder—Cisplatin—esophageal cancer	0.000148	0.00302	CcSEcCtD
Decitabine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000148	0.00301	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000147	0.00612	CbGpPWpGaD
Decitabine—Bronchitis—Capecitabine—esophageal cancer	0.000145	0.00296	CcSEcCtD
Decitabine—Alopecia—Cisplatin—esophageal cancer	0.000145	0.00295	CcSEcCtD
Decitabine—Pancytopenia—Capecitabine—esophageal cancer	0.000143	0.00292	CcSEcCtD
Decitabine—Erythema—Cisplatin—esophageal cancer	0.000143	0.00291	CcSEcCtD
Decitabine—Malnutrition—Cisplatin—esophageal cancer	0.000143	0.00291	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000142	0.00592	CbGpPWpGaD
Decitabine—Dysuria—Capecitabine—esophageal cancer	0.000141	0.00288	CcSEcCtD
Decitabine—Neutropenia—Capecitabine—esophageal cancer	0.000141	0.00288	CcSEcCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—CREBBP—esophageal cancer	0.000141	0.00589	CbGpPWpGaD
Decitabine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00014	0.00286	CcSEcCtD
Decitabine—Muscle spasms—Cisplatin—esophageal cancer	0.000137	0.0028	CcSEcCtD
Decitabine—Weight decreased—Capecitabine—esophageal cancer	0.000137	0.00278	CcSEcCtD
Decitabine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000136	0.00278	CcSEcCtD
Decitabine—Pneumonia—Capecitabine—esophageal cancer	0.000135	0.00276	CcSEcCtD
Decitabine—Infestation—Capecitabine—esophageal cancer	0.000135	0.00274	CcSEcCtD
Decitabine—Infestation NOS—Capecitabine—esophageal cancer	0.000135	0.00274	CcSEcCtD
Decitabine—Vision blurred—Cisplatin—esophageal cancer	0.000134	0.00274	CcSEcCtD
Decitabine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000134	0.00274	CcSEcCtD
Decitabine—Depression—Capecitabine—esophageal cancer	0.000134	0.00274	CcSEcCtD
Decitabine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000133	0.00271	CcSEcCtD
Decitabine—Lethargy—Methotrexate—esophageal cancer	0.000133	0.00271	CcSEcCtD
Decitabine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000132	0.0027	CcSEcCtD
Decitabine—Renal failure—Capecitabine—esophageal cancer	0.000132	0.0027	CcSEcCtD
Decitabine—Myocardial infarction—Capecitabine—esophageal cancer	0.000132	0.00269	CcSEcCtD
Decitabine—Anaemia—Cisplatin—esophageal cancer	0.000132	0.00269	CcSEcCtD
Decitabine—Stomatitis—Capecitabine—esophageal cancer	0.000131	0.00268	CcSEcCtD
Decitabine—Urinary tract infection—Capecitabine—esophageal cancer	0.000131	0.00267	CcSEcCtD
Decitabine—Malaise—Cisplatin—esophageal cancer	0.000129	0.00262	CcSEcCtD
Decitabine—Leukopenia—Cisplatin—esophageal cancer	0.000128	0.0026	CcSEcCtD
Decitabine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000127	0.0026	CcSEcCtD
Decitabine—Epistaxis—Capecitabine—esophageal cancer	0.000127	0.00259	CcSEcCtD
Decitabine—Myalgia—Cisplatin—esophageal cancer	0.000121	0.00248	CcSEcCtD
Decitabine—Haemoglobin—Capecitabine—esophageal cancer	0.000121	0.00248	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000121	0.00506	CbGpPWpGaD
Decitabine—Anxiety—Cisplatin—esophageal cancer	0.000121	0.00247	CcSEcCtD
Decitabine—Haemorrhage—Capecitabine—esophageal cancer	0.000121	0.00246	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000121	0.00246	CcSEcCtD
Decitabine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00012	0.00245	CcSEcCtD
Decitabine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00012	0.00245	CcSEcCtD
Decitabine—Discomfort—Cisplatin—esophageal cancer	0.00012	0.00245	CcSEcCtD
Decitabine—Pharyngitis—Capecitabine—esophageal cancer	0.00012	0.00245	CcSEcCtD
Decitabine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000119	0.00243	CcSEcCtD
Decitabine—Oedema peripheral—Capecitabine—esophageal cancer	0.000119	0.00243	CcSEcCtD
Decitabine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000119	0.00242	CcSEcCtD
Decitabine—Urethral disorder—Capecitabine—esophageal cancer	0.000118	0.00242	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NR1I2—esophageal cancer	0.000118	0.00494	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000118	0.00491	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000117	0.0049	CbGpPWpGaD
Decitabine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000116	0.00237	CcSEcCtD
Decitabine—Oedema—Cisplatin—esophageal cancer	0.000116	0.00237	CcSEcCtD
Decitabine—Infection—Cisplatin—esophageal cancer	0.000116	0.00236	CcSEcCtD
Decitabine—Nervous system disorder—Cisplatin—esophageal cancer	0.000114	0.00233	CcSEcCtD
Decitabine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000114	0.00233	CcSEcCtD
Decitabine—Tachycardia—Cisplatin—esophageal cancer	0.000114	0.00232	CcSEcCtD
Decitabine—Skin disorder—Cisplatin—esophageal cancer	0.000113	0.00231	CcSEcCtD
Decitabine—Eye disorder—Capecitabine—esophageal cancer	0.000113	0.0023	CcSEcCtD
Decitabine—Cardiac disorder—Capecitabine—esophageal cancer	0.000112	0.00229	CcSEcCtD
Decitabine—Anorexia—Cisplatin—esophageal cancer	0.000111	0.00226	CcSEcCtD
Decitabine—Angiopathy—Capecitabine—esophageal cancer	0.00011	0.00224	CcSEcCtD
Decitabine—Immune system disorder—Capecitabine—esophageal cancer	0.000109	0.00223	CcSEcCtD
Decitabine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000109	0.00222	CcSEcCtD
Decitabine—Hypotension—Cisplatin—esophageal cancer	0.000109	0.00222	CcSEcCtD
Decitabine—Chills—Capecitabine—esophageal cancer	0.000108	0.00221	CcSEcCtD
Decitabine—Alopecia—Capecitabine—esophageal cancer	0.000107	0.00218	CcSEcCtD
Decitabine—Pancytopenia—Methotrexate—esophageal cancer	0.000107	0.00218	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000106	0.00216	CcSEcCtD
Decitabine—Mental disorder—Capecitabine—esophageal cancer	0.000106	0.00216	CcSEcCtD
Decitabine—DNMT1—Gene Expression—SMG6—esophageal cancer	0.000105	0.0044	CbGpPWpGaD
Decitabine—Erythema—Capecitabine—esophageal cancer	0.000105	0.00214	CcSEcCtD
Decitabine—Malnutrition—Capecitabine—esophageal cancer	0.000105	0.00214	CcSEcCtD
Decitabine—Dysuria—Methotrexate—esophageal cancer	0.000105	0.00214	CcSEcCtD
Decitabine—Neutropenia—Methotrexate—esophageal cancer	0.000105	0.00214	CcSEcCtD
Decitabine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000104	0.00213	CcSEcCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—CCND1—esophageal cancer	0.000104	0.00436	CbGpPWpGaD
Decitabine—Dyspnoea—Cisplatin—esophageal cancer	0.000104	0.00212	CcSEcCtD
Decitabine—Back pain—Capecitabine—esophageal cancer	0.000102	0.00207	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—HIST1H2BM—esophageal cancer	0.000101	0.00423	CbGpPWpGaD
Decitabine—Decreased appetite—Cisplatin—esophageal cancer	0.000101	0.00206	CcSEcCtD
Decitabine—Muscle spasms—Capecitabine—esophageal cancer	0.000101	0.00206	CcSEcCtD
Decitabine—Pneumonia—Methotrexate—esophageal cancer	0.000101	0.00206	CcSEcCtD
Decitabine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000101	0.00205	CcSEcCtD
Decitabine—Infestation NOS—Methotrexate—esophageal cancer	0.0001	0.00204	CcSEcCtD
Decitabine—Infestation—Methotrexate—esophageal cancer	0.0001	0.00204	CcSEcCtD
Decitabine—Depression—Methotrexate—esophageal cancer	9.99e-05	0.00204	CcSEcCtD
Decitabine—Pain—Cisplatin—esophageal cancer	9.96e-05	0.00203	CcSEcCtD
Decitabine—Vision blurred—Capecitabine—esophageal cancer	9.91e-05	0.00202	CcSEcCtD
Decitabine—Renal failure—Methotrexate—esophageal cancer	9.85e-05	0.00201	CcSEcCtD
Decitabine—Stomatitis—Methotrexate—esophageal cancer	9.77e-05	0.00199	CcSEcCtD
Decitabine—Ill-defined disorder—Capecitabine—esophageal cancer	9.76e-05	0.00199	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	9.73e-05	0.00406	CbGpPWpGaD
Decitabine—Anaemia—Capecitabine—esophageal cancer	9.72e-05	0.00198	CcSEcCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	9.65e-05	0.00403	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—EP300—esophageal cancer	9.61e-05	0.00401	CbGpPWpGaD
Decitabine—Feeling abnormal—Cisplatin—esophageal cancer	9.6e-05	0.00196	CcSEcCtD
Decitabine—Malaise—Capecitabine—esophageal cancer	9.49e-05	0.00193	CcSEcCtD
Decitabine—Hepatobiliary disease—Methotrexate—esophageal cancer	9.48e-05	0.00193	CcSEcCtD
Decitabine—Epistaxis—Methotrexate—esophageal cancer	9.45e-05	0.00193	CcSEcCtD
Decitabine—Leukopenia—Capecitabine—esophageal cancer	9.42e-05	0.00192	CcSEcCtD
Decitabine—Body temperature increased—Cisplatin—esophageal cancer	9.21e-05	0.00188	CcSEcCtD
Decitabine—Cough—Capecitabine—esophageal cancer	9.18e-05	0.00187	CcSEcCtD
Decitabine—Hypertension—Capecitabine—esophageal cancer	9.08e-05	0.00185	CcSEcCtD
Decitabine—Haemoglobin—Methotrexate—esophageal cancer	9.04e-05	0.00184	CcSEcCtD
Decitabine—Haemorrhage—Methotrexate—esophageal cancer	9e-05	0.00183	CcSEcCtD
Decitabine—Arthralgia—Capecitabine—esophageal cancer	8.96e-05	0.00183	CcSEcCtD
Decitabine—Myalgia—Capecitabine—esophageal cancer	8.96e-05	0.00183	CcSEcCtD
Decitabine—Chest pain—Capecitabine—esophageal cancer	8.96e-05	0.00183	CcSEcCtD
Decitabine—Pharyngitis—Methotrexate—esophageal cancer	8.93e-05	0.00182	CcSEcCtD
Decitabine—Anxiety—Capecitabine—esophageal cancer	8.92e-05	0.00182	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	8.89e-05	0.00181	CcSEcCtD
Decitabine—Urinary tract disorder—Methotrexate—esophageal cancer	8.88e-05	0.00181	CcSEcCtD
Decitabine—Discomfort—Capecitabine—esophageal cancer	8.85e-05	0.0018	CcSEcCtD
Decitabine—Urethral disorder—Methotrexate—esophageal cancer	8.82e-05	0.0018	CcSEcCtD
Decitabine—DCK—Metabolism—BLVRB—esophageal cancer	8.72e-05	0.00364	CbGpPWpGaD
Decitabine—DCK—Metabolism—SLC52A3—esophageal cancer	8.72e-05	0.00364	CbGpPWpGaD
Decitabine—Gemcitabine—ABCB1—esophageal cancer	8.68e-05	0.0322	CrCbGaD
Decitabine—Confusional state—Capecitabine—esophageal cancer	8.66e-05	0.00177	CcSEcCtD
Decitabine—Oedema—Capecitabine—esophageal cancer	8.58e-05	0.00175	CcSEcCtD
Decitabine—Hypersensitivity—Cisplatin—esophageal cancer	8.58e-05	0.00175	CcSEcCtD
Decitabine—Infection—Capecitabine—esophageal cancer	8.53e-05	0.00174	CcSEcCtD
Decitabine—Nervous system disorder—Capecitabine—esophageal cancer	8.42e-05	0.00172	CcSEcCtD
Decitabine—Eye disorder—Methotrexate—esophageal cancer	8.41e-05	0.00171	CcSEcCtD
Decitabine—Thrombocytopenia—Capecitabine—esophageal cancer	8.41e-05	0.00171	CcSEcCtD
Decitabine—Tachycardia—Capecitabine—esophageal cancer	8.38e-05	0.00171	CcSEcCtD
Decitabine—Asthenia—Cisplatin—esophageal cancer	8.36e-05	0.0017	CcSEcCtD
Decitabine—Cardiac disorder—Methotrexate—esophageal cancer	8.35e-05	0.0017	CcSEcCtD
Decitabine—Skin disorder—Capecitabine—esophageal cancer	8.34e-05	0.0017	CcSEcCtD
Decitabine—Anorexia—Capecitabine—esophageal cancer	8.18e-05	0.00167	CcSEcCtD
Decitabine—Angiopathy—Methotrexate—esophageal cancer	8.16e-05	0.00166	CcSEcCtD
Decitabine—Immune system disorder—Methotrexate—esophageal cancer	8.12e-05	0.00166	CcSEcCtD
Decitabine—Mediastinal disorder—Methotrexate—esophageal cancer	8.11e-05	0.00165	CcSEcCtD
Decitabine—Chills—Methotrexate—esophageal cancer	8.07e-05	0.00165	CcSEcCtD
Decitabine—Hypotension—Capecitabine—esophageal cancer	8.02e-05	0.00164	CcSEcCtD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	7.99e-05	0.00333	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—NR1I2—esophageal cancer	7.99e-05	0.00333	CbGpPWpGaD
Decitabine—Diarrhoea—Cisplatin—esophageal cancer	7.97e-05	0.00162	CcSEcCtD
Decitabine—Alopecia—Methotrexate—esophageal cancer	7.95e-05	0.00162	CcSEcCtD
Decitabine—Lamivudine—ABCB1—esophageal cancer	7.9e-05	0.0293	CrCbGaD
Decitabine—Mental disorder—Methotrexate—esophageal cancer	7.88e-05	0.00161	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—PSME2—esophageal cancer	7.87e-05	0.00328	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PSME1—esophageal cancer	7.87e-05	0.00328	CbGpPWpGaD
Decitabine—Malnutrition—Methotrexate—esophageal cancer	7.83e-05	0.0016	CcSEcCtD
Decitabine—Erythema—Methotrexate—esophageal cancer	7.83e-05	0.0016	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	7.82e-05	0.00159	CcSEcCtD
Decitabine—Insomnia—Capecitabine—esophageal cancer	7.76e-05	0.00158	CcSEcCtD
Decitabine—Dyspnoea—Capecitabine—esophageal cancer	7.65e-05	0.00156	CcSEcCtD
Decitabine—Back pain—Methotrexate—esophageal cancer	7.57e-05	0.00154	CcSEcCtD
Decitabine—Dyspepsia—Capecitabine—esophageal cancer	7.56e-05	0.00154	CcSEcCtD
Decitabine—Decreased appetite—Capecitabine—esophageal cancer	7.46e-05	0.00152	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NOTCH3—esophageal cancer	7.42e-05	0.0031	CbGpPWpGaD
Decitabine—DCK—Metabolism—SLC10A2—esophageal cancer	7.42e-05	0.0031	CbGpPWpGaD
Decitabine—DCK—Metabolism—CA1—esophageal cancer	7.42e-05	0.0031	CbGpPWpGaD
Decitabine—Gastrointestinal disorder—Capecitabine—esophageal cancer	7.41e-05	0.00151	CcSEcCtD
Decitabine—Vomiting—Cisplatin—esophageal cancer	7.4e-05	0.00151	CcSEcCtD
Decitabine—Fatigue—Capecitabine—esophageal cancer	7.4e-05	0.00151	CcSEcCtD
Decitabine—Vision blurred—Methotrexate—esophageal cancer	7.38e-05	0.0015	CcSEcCtD
Decitabine—Rash—Cisplatin—esophageal cancer	7.34e-05	0.0015	CcSEcCtD
Decitabine—Pain—Capecitabine—esophageal cancer	7.34e-05	0.0015	CcSEcCtD
Decitabine—Constipation—Capecitabine—esophageal cancer	7.34e-05	0.0015	CcSEcCtD
Decitabine—Dermatitis—Cisplatin—esophageal cancer	7.34e-05	0.0015	CcSEcCtD
Decitabine—Ill-defined disorder—Methotrexate—esophageal cancer	7.27e-05	0.00148	CcSEcCtD
Decitabine—Anaemia—Methotrexate—esophageal cancer	7.24e-05	0.00148	CcSEcCtD
Decitabine—Feeling abnormal—Capecitabine—esophageal cancer	7.07e-05	0.00144	CcSEcCtD
Decitabine—Malaise—Methotrexate—esophageal cancer	7.06e-05	0.00144	CcSEcCtD
Decitabine—Gastrointestinal pain—Capecitabine—esophageal cancer	7.02e-05	0.00143	CcSEcCtD
Decitabine—Leukopenia—Methotrexate—esophageal cancer	7.01e-05	0.00143	CcSEcCtD
Decitabine—Nausea—Cisplatin—esophageal cancer	6.92e-05	0.00141	CcSEcCtD
Decitabine—DNMT1—Gene Expression—HIST1H2BM—esophageal cancer	6.85e-05	0.00286	CbGpPWpGaD
Decitabine—Cough—Methotrexate—esophageal cancer	6.83e-05	0.00139	CcSEcCtD
Decitabine—Urticaria—Capecitabine—esophageal cancer	6.82e-05	0.00139	CcSEcCtD
Decitabine—Abdominal pain—Capecitabine—esophageal cancer	6.79e-05	0.00138	CcSEcCtD
Decitabine—Body temperature increased—Capecitabine—esophageal cancer	6.79e-05	0.00138	CcSEcCtD
Decitabine—DCK—Metabolism—CA2—esophageal cancer	6.78e-05	0.00283	CbGpPWpGaD
Decitabine—Arthralgia—Methotrexate—esophageal cancer	6.67e-05	0.00136	CcSEcCtD
Decitabine—Myalgia—Methotrexate—esophageal cancer	6.67e-05	0.00136	CcSEcCtD
Decitabine—Chest pain—Methotrexate—esophageal cancer	6.67e-05	0.00136	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—NOTCH2—esophageal cancer	6.66e-05	0.00278	CbGpPWpGaD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	6.62e-05	0.00135	CcSEcCtD
Decitabine—Discomfort—Methotrexate—esophageal cancer	6.59e-05	0.00134	CcSEcCtD
Decitabine—Confusional state—Methotrexate—esophageal cancer	6.44e-05	0.00131	CcSEcCtD
Decitabine—Anaphylactic shock—Methotrexate—esophageal cancer	6.39e-05	0.0013	CcSEcCtD
Decitabine—Infection—Methotrexate—esophageal cancer	6.35e-05	0.00129	CcSEcCtD
Decitabine—Hypersensitivity—Capecitabine—esophageal cancer	6.32e-05	0.00129	CcSEcCtD
Decitabine—DCK—Metabolism—ADH7—esophageal cancer	6.31e-05	0.00263	CbGpPWpGaD
Decitabine—DCK—Metabolism—PLCE1—esophageal cancer	6.31e-05	0.00263	CbGpPWpGaD
Decitabine—Nervous system disorder—Methotrexate—esophageal cancer	6.27e-05	0.00128	CcSEcCtD
Decitabine—Thrombocytopenia—Methotrexate—esophageal cancer	6.26e-05	0.00128	CcSEcCtD
Decitabine—Skin disorder—Methotrexate—esophageal cancer	6.21e-05	0.00127	CcSEcCtD
Decitabine—Asthenia—Capecitabine—esophageal cancer	6.16e-05	0.00126	CcSEcCtD
Decitabine—Anorexia—Methotrexate—esophageal cancer	6.09e-05	0.00124	CcSEcCtD
Decitabine—Pruritus—Capecitabine—esophageal cancer	6.07e-05	0.00124	CcSEcCtD
Decitabine—Hypotension—Methotrexate—esophageal cancer	5.97e-05	0.00122	CcSEcCtD
Decitabine—Diarrhoea—Capecitabine—esophageal cancer	5.87e-05	0.0012	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	5.82e-05	0.00119	CcSEcCtD
Decitabine—Insomnia—Methotrexate—esophageal cancer	5.78e-05	0.00118	CcSEcCtD
Decitabine—Dyspnoea—Methotrexate—esophageal cancer	5.7e-05	0.00116	CcSEcCtD
Decitabine—Dizziness—Capecitabine—esophageal cancer	5.68e-05	0.00116	CcSEcCtD
Decitabine—Dyspepsia—Methotrexate—esophageal cancer	5.63e-05	0.00115	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—SMAD4—esophageal cancer	5.59e-05	0.00233	CbGpPWpGaD
Decitabine—Decreased appetite—Methotrexate—esophageal cancer	5.56e-05	0.00113	CcSEcCtD
Decitabine—DCK—Metabolism—ADH1B—esophageal cancer	5.53e-05	0.00231	CbGpPWpGaD
Decitabine—Gastrointestinal disorder—Methotrexate—esophageal cancer	5.52e-05	0.00113	CcSEcCtD
Decitabine—Fatigue—Methotrexate—esophageal cancer	5.51e-05	0.00112	CcSEcCtD
Decitabine—Pain—Methotrexate—esophageal cancer	5.46e-05	0.00111	CcSEcCtD
Decitabine—Vomiting—Capecitabine—esophageal cancer	5.46e-05	0.00111	CcSEcCtD
Decitabine—Rash—Capecitabine—esophageal cancer	5.41e-05	0.0011	CcSEcCtD
Decitabine—Dermatitis—Capecitabine—esophageal cancer	5.41e-05	0.0011	CcSEcCtD
Decitabine—Headache—Capecitabine—esophageal cancer	5.38e-05	0.0011	CcSEcCtD
Decitabine—DNMT1—Gene Expression—PSME2—esophageal cancer	5.32e-05	0.00222	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PSME1—esophageal cancer	5.32e-05	0.00222	CbGpPWpGaD
Decitabine—DCK—Metabolism—TYMP—esophageal cancer	5.28e-05	0.00221	CbGpPWpGaD
Decitabine—Feeling abnormal—Methotrexate—esophageal cancer	5.27e-05	0.00107	CcSEcCtD
Decitabine—Gastrointestinal pain—Methotrexate—esophageal cancer	5.23e-05	0.00107	CcSEcCtD
Decitabine—DCK—Metabolism—CYP26A1—esophageal cancer	5.14e-05	0.00215	CbGpPWpGaD
Decitabine—Nausea—Capecitabine—esophageal cancer	5.1e-05	0.00104	CcSEcCtD
Decitabine—Urticaria—Methotrexate—esophageal cancer	5.08e-05	0.00104	CcSEcCtD
Decitabine—Body temperature increased—Methotrexate—esophageal cancer	5.05e-05	0.00103	CcSEcCtD
Decitabine—Abdominal pain—Methotrexate—esophageal cancer	5.05e-05	0.00103	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NOTCH3—esophageal cancer	5.02e-05	0.00209	CbGpPWpGaD
Decitabine—DCK—Metabolism—ALOX15—esophageal cancer	5.01e-05	0.00209	CbGpPWpGaD
Decitabine—DCK—Metabolism—GSTO1—esophageal cancer	4.78e-05	0.00199	CbGpPWpGaD
Decitabine—DCK—Metabolism—TPI1—esophageal cancer	4.78e-05	0.00199	CbGpPWpGaD
Decitabine—Hypersensitivity—Methotrexate—esophageal cancer	4.71e-05	0.00096	CcSEcCtD
Decitabine—Asthenia—Methotrexate—esophageal cancer	4.59e-05	0.000935	CcSEcCtD
Decitabine—DCK—Metabolism—ALDOB—esophageal cancer	4.58e-05	0.00191	CbGpPWpGaD
Decitabine—Pruritus—Methotrexate—esophageal cancer	4.52e-05	0.000922	CcSEcCtD
Decitabine—DNMT1—Gene Expression—NOTCH2—esophageal cancer	4.5e-05	0.00188	CbGpPWpGaD
Decitabine—DCK—Metabolism—GAPDH—esophageal cancer	4.41e-05	0.00184	CbGpPWpGaD
Decitabine—Diarrhoea—Methotrexate—esophageal cancer	4.37e-05	0.000892	CcSEcCtD
Decitabine—DCK—Metabolism—CRABP1—esophageal cancer	4.37e-05	0.00182	CbGpPWpGaD
Decitabine—Dizziness—Methotrexate—esophageal cancer	4.23e-05	0.000862	CcSEcCtD
Decitabine—DCK—Metabolism—GNG7—esophageal cancer	4.16e-05	0.00174	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—NOTCH1—esophageal cancer	4.12e-05	0.00172	CbGpPWpGaD
Decitabine—Vomiting—Methotrexate—esophageal cancer	4.06e-05	0.000829	CcSEcCtD
Decitabine—Rash—Methotrexate—esophageal cancer	4.03e-05	0.000822	CcSEcCtD
Decitabine—Dermatitis—Methotrexate—esophageal cancer	4.03e-05	0.000821	CcSEcCtD
Decitabine—Headache—Methotrexate—esophageal cancer	4e-05	0.000816	CcSEcCtD
Decitabine—DCK—Metabolism—ALDH2—esophageal cancer	3.9e-05	0.00163	CbGpPWpGaD
Decitabine—Nausea—Methotrexate—esophageal cancer	3.8e-05	0.000774	CcSEcCtD
Decitabine—DNMT1—Gene Expression—SMAD4—esophageal cancer	3.78e-05	0.00158	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—CREBBP—esophageal cancer	3.74e-05	0.00156	CbGpPWpGaD
Decitabine—DCK—Metabolism—GSTT1—esophageal cancer	3.71e-05	0.00155	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYP2A6—esophageal cancer	3.66e-05	0.00153	CbGpPWpGaD
Decitabine—DCK—Metabolism—ENO1—esophageal cancer	3.47e-05	0.00145	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTGS1—esophageal cancer	3.47e-05	0.00145	CbGpPWpGaD
Decitabine—DCK—Metabolism—PSME2—esophageal cancer	3.42e-05	0.00143	CbGpPWpGaD
Decitabine—DCK—Metabolism—PSME1—esophageal cancer	3.42e-05	0.00143	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYP1B1—esophageal cancer	2.95e-05	0.00123	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—NOTCH1—esophageal cancer	2.78e-05	0.00116	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYP19A1—esophageal cancer	2.78e-05	0.00116	CbGpPWpGaD
Decitabine—DCK—Metabolism—HMOX1—esophageal cancer	2.53e-05	0.00106	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—CREBBP—esophageal cancer	2.52e-05	0.00105	CbGpPWpGaD
Decitabine—DCK—Metabolism—ABCB1—esophageal cancer	2.43e-05	0.00101	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—MYC—esophageal cancer	2.22e-05	0.000926	CbGpPWpGaD
Decitabine—DCK—Metabolism—CREBBP—esophageal cancer	1.62e-05	0.000678	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MYC—esophageal cancer	1.5e-05	0.000625	CbGpPWpGaD
Decitabine—DCK—Metabolism—NOS3—esophageal cancer	1.45e-05	0.000607	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTGS2—esophageal cancer	1.33e-05	0.000555	CbGpPWpGaD
Decitabine—DCK—Metabolism—EP300—esophageal cancer	1.11e-05	0.000462	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CA—esophageal cancer	8.19e-06	0.000342	CbGpPWpGaD
